Scarica l'app Stockscreener
90.31
0.83%
0.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Alcon Inc Borsa (ALC) Ultime notizie
Alcon Hit With Suit Over Allegedly Contaminated Eye Drops - Law360
Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 Earnings - MSN
Alcon launches Voyager laser trabeculoplasty platform in US - Optics.org
Alcon Releases Voyager DSLT for Glaucoma & Ocular Hypertension in U.S. - MPO-mag
Alcon to Roll Out New Glaucoma, Ocular Hypertension Laser Therapy in US -February 19, 2025 at 09:17 am EST - Marketscreener.com
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension - Business Wire
Alcon Inc.'s (VTX:ALC) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Simply Wall St
Growth Report 2: Alcon Mechanical Plans Tech Investments - businessjournaldaily.com
Judge Finds No Infringement In Alcon's Eye Drop Patent Suit - Law360
Alcon Fights for Veto Rights in Aurion's Planned Public Offering - Bloomberg Law
Alcon Loses Patent Ruling on Padagis Copy of Simbrinza Eye Drops - Bloomberg Law
Alcon: T. Rowe Price above 3% of voting rights -February 10, 2025 at 10:40 am EST - Marketscreener.com
Tesla, Musk, Warner Bros. Ask To Toss 'Blade Runner' AI Suit - Law360
Alcon: An Eyecare Leader With Strong Profit Margins, But Overheated Valuation - Seeking Alpha
Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL
Alcon Loses Bid to Veto Aurion IPO, Can Still Oppose Listing (1) - Bloomberg Law
Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch Health, Hoya, Johnson & Johnson, STAAR Surgical Co, Carl Zeiss Meditec, and Novartis - GlobeNewswire
Alcon stock price target cut to $106 by Needham, maintains Buy - MSN
Alcon Breaks Above 200-Day Moving AverageBullish for ALC - Nasdaq
Artificial Tears Market Overall Study Report 2025-2032 | - openPR
Alcon stock price target cut to $105 by KeyBanc - MSN
Apple To $253? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Do Options Traders Know Something About Alcon (ALC) Stock We Don't? - Yahoo Finance
First Week of March 21st Options Trading For Alcon (ALC) - Nasdaq
Alcon Inc (ALC) Shares Up 3.7% on Jan 21 - GuruFocus.com
Modernizing a Legacy Application on AWS Serverless with Alcon - AWS Blog
Modernizing a Legacy Application on AWS Serverless with Alcon | Case Study | AWS - AWS Blog
Alcon to Seek M&A -January 14, 2025 at 07:30 pm EST - Marketscreener.com
Should Weakness in Alcon Inc.'s (VTX:ALC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Finance
Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge - GlobeNewswire Inc.
Redburn raises Alcon stock rating to Buy By Investing.com - Investing.com Nigeria
Redburn raises Alcon stock rating to Buy - Investing.com
Dry Eye Disease Market Is Booming Worldwide 2025-2032 | Novartis - openPR
Contact Lens Market Deep Research Report with Forecast by 2031 | Bausch & Lomb Incorporated, Alcon Vision LLC - EIN News
Alcon Inc. (VTX:ALC) is favoured by institutional owners who hold 63% of the company - Simply Wall St
Seeing Brilliance in APAC: Alcon’s Vision Care Innovations and Eye Health Mission - BSA bureau
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Alcon Laboratories issues recall for Systane eye drops due to fungal contamination - Top Class Actions
News Release – DOH Issues Recall Alert For Alcon Laboratories Systane Brand Lubricant Eye Drops Due to Fungal - EIN News
DOH issues recall alert for Alcon Laboratories Systane Brand Lubricant Eye Drops - Maui Now
Alcon Labs recalling eye drops - Valley News
Alcon Laboratories Recalls Systane Eye Drops Nationwide Over Fungal Contamination Risk - Black Enterprise
Alcon's (VTX:ALC) investors will be pleased with their respectable 41% return over the last five years - Simply Wall St
0.47%
1.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):